Each year JPM Week brings together health innovators and investors to refresh or make the connections that drive health Invaton Forward Faster. See where thy are in the spotlight this week.
AZBio and the State Bio Friends kicked thing off on Sunday, January 12, 2025, as hundreds of companies and investors came together at The Marker San Francisco. This exclusive, invitation only event is a perennial favorite bring people together from coast to coast.
Presentations begin Monday at Bio Tech Showcase and continue in person through Wednesday with virtual partnering continuing on January 21 & 22. Here you can meet with:
- The Arizona Bioindustry Association, Inc. (AZBio) supports life science innovation and life science innovators in Arizona. A key component in Arizona’s life science ecosystem, AZBio is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio president & CEO, will moderate pitch presentations on Monday morning
- Aspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing.
- Xcellerant Ventures is a venture capital company that invests in technologies that power the future of healthcare by providing solutions that improve quality, efficiency, access, and delivery of care at lowered costs.
- NuvOx develops a novel oxygen therapeutic platform, delivering oxygen to tissue level and reverse hypoxia, the root cause of many life-threatening diseases, applicable in oncology, stroke, ARDS, etc.
- SPOC Proteomics has developed a breakthrough ‘DNA library to Protein library’ technology to democratize proteomics ($75B market), with transformative applications in preclinical drug discovery, plasma proteomics, and multi-disease diagnostics.
- Microvascular Therapeutics Inc. (MVT) is a clinical-stage biotech. MVT recently completed a phase II study for a microbubble contrast agent which is being developed through an accelerated pathway.
- Aqualung Therapeutics is a biotech company that has developed a next generation mAb that targets an upstream protein/biomarker (eNAMPT), which treats “unchecked inflammation and fibrosis”.
RESI, hosted by Life Science Nation, kicks off on Tuesday with in person sessions followed by virtal partnering sessions ending on January 21st. Connect with these Arizonans at RESI:
- AZBio
- biolaw.ai is a leading legal technology company dedicated to empowering life science entrepreneurs with innovative, affordable solutions to address legal and operational challenges.
- Evidence Ventures is a venture capital firm with venture studio capabilities, investing primarily in very early-stage companies, from pre-seed to seed stages. The firm’s average check size ranges from $250,000 to $500,000. While Evidence VC is focused on the US, particularly in California and the Phoenix.
- Hoolest creates accelerated nervous system recovery tools through auricular vagus nerve stimulation. Since covid, there has been massive demand for better drug-free tools to help improve nervous system health and wellness.
- SPOC Proteomics
- Xcellerant Ventures
The J.P. Morgan Healthcare Conference, takes place January 13-16, 2025
- Bristol Myers Squibb (NYSE: BMY) is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
- Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer.
- Castle Biosciences, Inc. (Nasdaq: CSTL) is a company improving health through innovative tests that guide patient care.
- DexCom, Inc. (NASDAQ:DXCM) empowers people to take control of health through innovative biosensing technology.
- Exact Sciences Corp. (Nasdaq: EXAS) is a leading provider of cancer screening and diagnostic tests.
- Medtronic plc (NYSE:MDT) is a global leader in healthcare technology.
- West Pharmaceutical Services, Inc. (NYSE: WST) is a global leader in innovative solutions for injectable drug administration